Sign Up to like & get
recommendations!
0
Published in 2021 at "Rheumatology International"
DOI: 10.1007/s00296-020-04774-3
Abstract: To examine whether treatment with interleukin (IL)-1-, IL-6-, tumour necrosis factor α (TNFα)-inhibitors or Abatacept is associated with an increased risk of common infections, infections requiring hospitalization (SAE) or opportunistic infections among real-world juvenile idiopathic…
read more here.
Keywords:
real world;
risk;
juvenile idiopathic;
jia ... See more keywords